Gatifloxacin CAS:112811-59-3
Ana yawan rubuta Gatifloxacin a asibitoci don magance cututtukan ƙwayoyin cuta kamar ciwon huhu da ke kama da na al'umma, mashako, sinusitis, cututtukan fitsari, da cututtukan fata. Maganin da ake amfani da shi ta baki yana da kyau ga cututtuka na tsarin jiki, yayin da ake amfani da maganin ido don magance matsalolin ido kamar conjunctivitis na ƙwayoyin cuta da gyambon cornea. Masu ba da sabis na kiwon lafiya suna ƙayyade adadin gatifloxacin da ya dace bisa ga abubuwan da suka shafi nau'in kamuwa da cuta, tsananinsa, shekarun majiyyaci, nauyi, aikin koda, da sakamakon gwajin kamuwa da ƙwayoyin cuta idan akwai. Bin ƙa'idodin allurai da aka tsara yana da mahimmanci don cimma sakamako mafi kyau na magani da hana ci gaban juriya. Ana shawartar marasa lafiya da su kammala cikakken maganin gatifloxacin koda kuwa alamun sun inganta don tabbatar da kawar da ƙwayoyin cuta masu kamuwa da cuta. Kula da martanin magani, yuwuwar illa, da hulɗar magunguna yana da mahimmanci yayin jiyya. Duk da cewa gabaɗaya ana jure shi da kyau, illolin gatifloxacin na iya haɗawa da rikicewar hanji, jiri, ko halayen fata. Masana kiwon lafiya suna sa ido kan illolin da ba kasafai ake samu ba amma masu tsanani kamar fashewar jijiya ko tasirin tsarin jijiyoyi na tsakiya, musamman a wasu mutanen da ke fama da cutar. Ziyarar da ake yi akai-akai tare da masu kula da lafiya na taimakawa wajen tantance ci gaban magani, daidaita magani kamar yadda ake buƙata, da kuma haɓaka sakamako mai kyau yayin amfani da gatifloxacin wajen magance cututtukan ƙwayoyin cuta. Haɗin gwiwa tsakanin marasa lafiya, masu kula da marasa lafiya, da ƙwararrun ma'aikatan kiwon lafiya yana da mahimmanci don tabbatar da amfani da wannan maganin rigakafi cikin aminci da inganci da kuma inganta sakamakon marasa lafiya.
| Tsarin aiki | C19H22FN3O4 |
| Gwaji | 99% |
| Bayyanar | farin foda |
| Lambar CAS | 112811-59-3 |
| shiryawa | Ƙarami da girma |
| Rayuwar shiryayye | Shekaru 2 |
| Ajiya | A adana a wuri mai sanyi da bushewa |
| Takardar shaida | ISO. |








